Lab Information

Arielle Mendel (MD/MSc)

Junior Scientist
Centre for Outcomes Research and Evaluation
Department of Medicine (McGill)

Research Profile

 Fundamental: 0%
 Clinical: 20%
 Epidemiology: 30%
 Evaluation: 50%
 This email address is being protected from spambots. You need JavaScript enabled to view it.


Systemic autoimmune rheumatic diseases • systemic vasculitis • systemic lupus erythematosus • patient safety and quality improvement • medication safety

Research Interests

My research focuses on patient safety in systemic autoimmune rheumatic disease. I aim to improve medication safety in this population by studying root causes of adverse drug events, with a particular focus on glucocorticoids (i.e., prednisone) and other immunosuppressive agents, in order to design innovative strategies for improving medication safety in this population.

Team Members

Name Position

Latest Publications

  1. Sacre, K., Vinet, E., Pineau, C. A., Mendel, A., Kalache, F., Grenier, L.-P., Huynh, T. & Bernatsky, S. (2023). N-Terminal pro-Brain Natriuretic Peptide is a biomarker for cardiovascular damage in systemic lupus erythematous: a cross-sectional study. Rheumatology (Oxford, England).
  2. Semionov, A., Azuelos, I. & Mendel, A. (2023). Unilateral metastatic pulmonary calcification in context of ipsilateral central pulmonary embolism. Radiology case reports, vol. 18, p. 4239-4242.
  3. Mendel, A., Behlouli, H., de Moura, C. S., Vinet, É., Curtis, J. R. & Bernatsky, S. (2023). Trimethoprim-sulfamethoxazole prophylaxis during treatment of granulomatosis with polyangiitis with rituximab in the United States of America: a retrospective cohort study. Arthritis research & therapy, vol. 25, p. 133.
  4. Hanula, R., Bortolussi-Courval, É., Mendel, A., Ward, B. J., Lee, T. C. & McDonald, E. G. (2023). Evaluation of Oseltamivir Used to Prevent Hospitalization in Outpatients With Influenza: A Systematic Review and Meta-analysis. JAMA internal medicine.
  5. Lee, J.-E., Mendel, A., Askanase, A., Bae, S.-C., Buyon, J. P., Clarke, A. E., Costedoat-Chalumeau, N., Fortin, P. R., Gladman, D. D., Ramsey-Goldman, R., Hanly, J. G., Inanç, M., Isenberg, D. A., Mak, A., Mosca, M., Petri, M., Rahman, A., Sanchez-Guerrero, J., Urowitz, M., Wallace, D. J., Bernatsky, S. & Vinet, É. (2023). Systemic Lupus Erythematosus Women with Lupus Nephritis in Pregnancy Therapeutic Challenge (SWITCH): The Systemic Lupus International Collaborating Clinics experience. Annals of the rheumatic diseases, vol. 82, p. 1496-1497.
  6. Turgeon, D., Bakowsky, V., Baldwin, C., Cabral, D. A., Clements-Baker, M., Clifford, A., Cohen Tervaert, J. W., Dehghan, N., Ennis, D., Famorca, L., Fifi-Mah, A., Girard, L.-P., Lefebvre, F., Liang, P., Makhzoum, J.-P., Massicotte-Azarniouch, D., Mendel, A., Milman, N., Reich, H. N., Robinson, D. B., Ross, C., Rumsey, D. G., Soowamber, M., Towheed, T. E., Trudeau, J., Twilt, M., Yacyshyn, E., Yardimci, G. K., Khalidi, N., Barra, L. & Pagnoux, C. (2023). CanVasc consensus recommendations for the use of avacopan in antineutrophil cytoplasm antibody-associated vasculitis: 2022 addendum. Rheumatology (Oxford, England), vol. 62, p. 2646-2651.
  7. Mendel, A., Fritzler, M. J., St-Pierre, Y., Rauch, J., Bernatsky, S. & Vinet, É. (2023). Outcomes associated with antiphospholipid antibodies in COVID-19: A prospective cohort study. Research and practice in thrombosis and haemostasis, vol. 7, p. 100041.
  8. Mendel, A., Colmegna, I., Bourque, G., Rajda, E., Lee, T. C., Gálvez, J. H., Vinet, É. & Cheng, M. P. (2022). More than a 'Hundred Days War': Persistent SARS-CoV-2 infection in a patient with ANCA-associated vasculitis. Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada, vol. 7, p. 131-134.
  9. Eder, L., Croxford, R., Drucker, A. M., Mendel, A., Kuriya, B., Touma, Z., Johnson, S. R., Cook, R., Bernatsky, S., Haroon, N. & Widdifield, J. (2022). COVID-19 Hospitalizations, Intensive Care Unit Stays, Ventilation, and Death Among Patients With Immune-mediated Inflammatory Diseases Compared to Controls. The Journal of rheumatology, vol. 49, p. 523-530.
  10. Barber, C. E. H., Levy, D. M., Ahluwalia, V., Mendel, A., Taylor-Gjevre, R., Gerschman, T., Koppikar, S., Jilkine, K., Stringer, E., Barnabe, C., Aydin, S. Z., Luca, N., Berard, R., Tam, K., Burt, J., Murdoch, J. C., Zinck, G., Lane, T., Heeley, J., Mannerow, M., Mills, R., Wilhelm, L., Hartfeld, N. M. S. & Ohata, B. (2022). Best Practices for Virtual Care: A Consensus Statement From the Canadian Rheumatology Association. The Journal of rheumatology, vol. 49, p. 408-418.
More on PubMed 

See also

Card image

See profile
Card image

See profile
Card image

See profile
Card image

See profile
Card image

See profile
Card image

See profile